Ginkgo Bioworks Holdings DNA
NYSE DNA
$12.49 -0.34 (-2.65%)
As of: Oct 1, 2026 · 3:59 PM EDT

Ginkgo Bioworks Holdings (DNA) Liabilities and Shareholders Equity (2020 - 2026)

Updated

Ginkgo Bioworks Holdings' Liabilities and Shareholders Equity came in at $990.05 million for Q2 2026, down 19.6% from $1.23 billion a year earlier and down 4.2% from the prior quarter.

Analysis

Ginkgo Bioworks Holdings (DNA) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends

At the end of FY2025, Ginkgo Bioworks Holdings' Liabilities and Shareholders Equity was $1.12 billion, down 18.7% from FY2024.

  • Liabilities and Shareholders Equity has declined in each of the last three years, though with a five-year compound annual growth rate of 10.6% (FY2020 to FY2025).
  • Going back by year, Liabilities and Shareholders Equity was $1.38 billion in FY2024 (-17.3%), $1.67 billion in FY2023 (-34.4%), $2.54 billion in FY2022 (+22.6%) and $2.07 billion in FY2021 (+206.7%).
  • The Q2 2026 figure represents the lowest quarterly Liabilities and Shareholders Equity since Q4 2020.
  • Year-over-year, Liabilities and Shareholders Equity has declined for 11 consecutive quarters, with an average decline of 20.6% over the last eight quarters.
  • The fastest year-over-year change in Liabilities and Shareholders Equity over five years came in Q4 2021 (growth of 206.7%), and the weakest in Q1 2024 (a decline of 34.6%).
  • Business Quant data shows DNA's Liabilities and Shareholders Equity at $1.03 billion (Q1 2026), $1.12 billion (Q4 2025) and $1.19 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Iqvia Holdings 44.26 Bn 36.10 Bn 1.44 Bn 29.88 Bn
2 Medpace Holdings 17.42 Bn 15.48 Bn 201.64 Mn 2.06 Bn
3 Charles River Laboratories International 14.08 Bn 13.32 Bn 363.37 Mn 7.53 Bn
4 Icon 13.02 Bn 10.12 Bn 479.29 Mn 16.40 Bn
5 Fortrea Holdings 1.90 Bn 1.28 Bn 139.20 Mn 2.71 Bn
6 Ginkgo Bioworks Holdings 817.41 Mn 55.33 Mn 18.44 Mn 990.05 Mn
7 Evotec SE 608.00 Mn -965.22 Mn - 1.83 Bn
8 Champions Oncology 69.59 Mn 45.24 Mn 7.70 Mn 33.29 Mn
9 MindWalk Holdings 62.13 Mn 26.34 Mn 1.61 Mn 12.42 Mn
10 Natural Alternatives International 8.98 Mn -19.10 Mn 1.73 Mn 126.45 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 990.05 Mn
Mar 31, 2026 1.03 Bn
Dec 31, 2025 1.12 Bn
Sep 30, 2025 1.19 Bn
Jun 30, 2025 1.23 Bn
Mar 31, 2025 1.29 Bn
Dec 31, 2024 1.38 Bn
Sep 30, 2024 1.48 Bn
Jun 30, 2024 1.63 Bn
Mar 31, 2024 1.58 Bn
Dec 31, 2023 1.67 Bn
Sep 30, 2023 2.03 Bn
Jun 30, 2023 2.29 Bn
Mar 31, 2023 2.42 Bn
Dec 31, 2022 2.54 Bn
Sep 30, 2022 1.87 Bn
Jun 30, 2022 1.99 Bn
Mar 31, 2022 2.06 Bn
Dec 31, 2021 2.07 Bn
Sep 30, 2021 2.15 Bn
API Access

Ginkgo Bioworks Holdings Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=DNA&period=max&api_key=YOUR_API_KEY